Financial Risk Management

Risk Measurement and Management

Risk Measurement and Management

Many companies are trying to enhance their measurement and management of risk. Senior managers seeking to implement best practices at their company face a two-fold problem. First, they must understand and implement current best practices (if they exist) that apply to their business. These practices can vary widely from industry to industry. For example, in the financial services industry, various value-at-risk and stress-testing approaches have long been the preferred risk management tools. Though some of these core methods are well known, poor model design and choices can— and have—resulted in major, unexpected, and potentially preventable losses.

For non-financial companies whose assets are primarily intangible, measuring the value and the associated risks of these assets has long been a problem. In addition to the same dangers of poor model design and choice faced by financial services firms, these companies do not even have a best practices approach to risk management. NERA works with non-financial companies using our f-irm (financially integrated risk model) to better measure and manage cash-flow-at-risk.

Second, senior managers are challenged to keep abreast of best practices as they evolve; NERA’s risk experts play a vital role in keeping clients informed of new developments. Our experts have assisted various industry bodies, such as the Group of Thirty, the International Swaps and Derivatives Association, the Committee of Chief Risk Officers, and the Treasury Management Association in developing risk management principles and evaluating best practices.

NERA is recognized as a leader in the measurement and management of the full range of financial risk faced by organizations, including market risk, credit risk, liquidity risk, and operational risk.

Name Title Location Phone Email
Dr. Airat Chanyshev Associate Director New York City +1 212 345 7336 airat.chanyshev@nera.com
Dr. Jordan Milev Associate Director New York City +1 212 345 5516 jordan.milev@nera.com
Dr. Sharon Brown-Hruska Affiliated Consultant Washington, DC +1 202 466 3510 sharon.hruska.affiliate@nera.com
Dr. Andrew Carron Affiliated Consultant New York City
London
+1 212 345 5407
+44 20 7659 8500
andrew.carron.affiliate@nera.com
Jonathan Falk Affiliated Consultant New York City +1 212 345 5315 jonathan.falk.affiliate@nera.com
Dr. James Jordan Affiliated Consultant Washington, DC +1 202 466 9263 james.jordan.affiliate@nera.com
Title Type Author
‘Coca-Cola’ vs. Section 482: Is It Time to Refresh the Regulatory Guidance? Published Article Dr. Harlow Higinbotham and Dr. Niraja Srinivasan
The Future of Transfer Pricing Published Article Niraja Srinivasan, et al.
Snapshot of Recent Trends in Asbestos Litigation 2021 Update Mary Elizabeth C. Stern and Lucy P. Allen
NERA Experts Contribute Chapter to "The Future of the Profit Split Method" Book Dr. Harlow Higginbotham and Dr. Vladimir Starkov
Trends in Canadian Securities Class Actions: 2020 Update Report Bradley A. Heys, Robert Patton, and Jielei Mao
Transfer Pricing Roundtable in Financier Worldwide. Expert QA Dr. Vladimir Starkov and Philip de Homont
Amount B: Facts and Circumstances Matter—Even for Routine Distributors Published Article Dr. Harlow Higinbotham, Dr. Niraja Srinivasan, Dr. Vladimir Starkov, and Nihan Mert-Beydilli
Recent Trends in Securities Class Action Litigation: 2020 Full-Year Review Report Janeen McIntosh and Svetlana Starykh
Recent Trends in Securities Class Action Litigation: H1 2020 Update Report Janeen McIntosh and Svetlana Starykh
How COVID-19 Impact Analysis May Shape MAE Disputes Published Article Dr. David Tabak and Edward Flores